Back to mobile site

Canaccord Genuity Reiterates a 'Buy' on OraSure Technologies (OSUR); Identifies MDx Entry Point

July 26, 2011 10:02 AM EDT
Get Alerts OSUR Hot Sheet
Price: $3.85 +2.94%

Rating Summary:
    9 Buy, 8 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on OraSure Technologies (NASDAQ: OSUR) price target of $10.00.

Canaccord analyst, Jeffrey Frelick, said, "OraSure announced after the close its intention to acquire DNA Genotek for $53M in cash. We view the deal as very strategic and synergistic given OraSure’s oral fluid technology and reiterate our rating...OraSure gains entry into molecular diagnostics market. While some et. companies are investing large sums to participate in the MDx market, OSUR was able to secure a strategic entry point to the fastest growing segment in diagnostics."

For more ratings news on OraSure Technologies click here and for the rating history of OraSure Technologies click here.

Shares of OraSure Technologies closed at $9.25 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments